Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 135-710, South Korea.
World J Gastroenterol. 2011 Aug 21;17(31):3591-5. doi: 10.3748/wjg.v17.i31.3591.
Endoscopic treatment, such as endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), has been established as one of the treatment options for selected cases with early gastric cancer (EGC). Most studies on this topic have been carried out by researchers in Japan. Recently, the experience in EMR/ESD for EGC outside Japan is increasingly reported. In Korea, gastric cancer is the most common malignant disease, and the second leading cause of cancer death. Currently, EMR for EGC is widely performed in many centers in Korea. Early results with a short-term follow-up period are very promising in Korea. The complete resection rate of EMR was 37.8%-94.3%, and that of ESD was 77.4%-93.1%. In this review, we will provide an overview of the outcomes of endoscopic treatments in Korea.
内镜治疗,如内镜黏膜切除术(EMR)和内镜黏膜下剥离术(ESD),已被确立为早期胃癌(EGC)的一种治疗选择。这方面的大多数研究都是由日本的研究人员进行的。最近,越来越多的日本以外国家报告了 EMR/ESD 治疗 EGC 的经验。在韩国,胃癌是最常见的恶性疾病,也是癌症死亡的第二大原因。目前,韩国许多中心广泛开展 EGC 的 EMR 治疗。在韩国,短期随访的早期结果非常有希望。EMR 的完全切除率为 37.8%-94.3%,ESD 的完全切除率为 77.4%-93.1%。在这篇综述中,我们将概述韩国内镜治疗的结果。